Eczema
Reduces itch and redness.
Eucrisa vs Vtama
Eucrisa: A non-steroid ointment for mild to moderate eczema. It can be used on the face and in skin folds, and there is no limit on how long it can be used. Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping.
Which one is right for you?
Choose Eucrisa if…
Choose for mild to moderate eczema when you want a non-steroid you can use anywhere, for as long as needed.
- Mild eczema on the face or folds
- You want no time limit on use
- Insurance covers it or savings apply
Choose Vtama if…
Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.
- Psoriasis on the face or folds
- You want to avoid steroid thinning
- Once-daily use suits you
Alternatives, not combined
Can you take them together?
Both are steroid-free eczema creams. Most people use one or the other.
At a glance
● Eucrisa
● Vtama
Type
Topical PDE4 inhibitor (crisaborole 2%)
Topical AhR agonist (tapinarof 1%)
What it does
Calms eczema inflammation without a steroid
Calms inflammation and restores the skin barrier
Best for
Mild to moderate eczema, including face and folds
Plaque psoriasis and eczema, including face and folds
Prescription
Yes
Yes
Form
Ointment
Cream
How often
Twice daily
Once daily
Course length
No time limit
No time limit
Time to results
Up to 4 weeks
8–12 weeks
Main side effect
Burning or stinging where applied
Folliculitis
Blood tests
None
None
Pregnancy
Check with your clinician
Check with your clinician
Cost
High; brand only
High; brand only
What it treats
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.
Evidence level
Eucrisa
Vtama
Strong evidenceMost established uses
—
Psoriasis
Clears plaques without steroids.
Moderate evidenceSome supportive research
Eczema
Reduces itch and redness.
—
Little evidence
Psoriasis
Not approved for psoriasis.
Rosacea
Not studied for rosacea.
Not effective
Acne
No role in acne.
—
Can make it worse
—
Acne
Folliculitis and acne are possible side effects.
How it works
Eucrisa
Diagram explanation and sources
Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Eczema redness and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
Vtama
Diagram explanation and sources
Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.
Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.
How you take it
Treatment plan
When to Apply: A thin layer twice a day on the inflamed areas, on clean dry skin. Moisturizer goes everywhere, including over the top once it has settled.
How to Start: Twice daily from day one, on the flaring areas only, not over the whole body as a preventive. If the stinging is hard to tolerate, moisturize first and use the ointment straight from the fridge. The stinging usually fades within the first week.
If It Irritates: Burning or stinging for a few minutes after applying is the commonest effect, and usually not an allergy. It settles as the skin heals. Redness spreading beyond where you applied it, or stinging that gets worse rather than better after two weeks, should be reviewed.
If It's Not Working: There is one strength, so there is nothing to increase. Four weeks of proper twice-daily use is a fair trial. After that: a different non-steroid, a short steroid course to break the flare, or a look at what else is driving the rash.
When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.
How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.
If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.
If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.
Monitoring
No blood tests and no routine monitoring. Very little reaches the bloodstream, and what does is broken down quickly, so nothing accumulates.
Monitoring is a review at about four weeks to decide whether it is working. Long term, this is a drug people can stay on: no maximum duration, no limit on the area treated, no rest period. That is the practical difference between it and a topical steroid.
The one thing worth watching is whether it is quietly standing in for treatment that would actually control the disease. Eczema that keeps escaping it needs a different plan, not more months of the same ointment.
No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.
Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.
Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.
When you’ll see results
Approximate windows, not promises.
● Eucrisa
● Vtama
First few minutes
First few minutesApplying it: A thin layer twice a day. Stinging or warmth for a few minutes is common, worst in week one.
First few minutesApplying it: A thin layer once a day on the plaques.
Days 1 to 7
Days 1 to 7Adjusting: Stinging is at its worst now. Itch eases before the rash looks different.
Week 2
Week 2Settling: Redness and scaling fade. Most of the stinging has gone.
Week 4
Week 4Judge it here: The point the trials measured. A meaningful share of people reach clear or almost clear skin; a meaningful share do not. No change by four weeks means more time will not help.
Ongoing
OngoingFace, eyelids and folds: Its strongest case. Use it on and off as needed: no cumulative limit, no rest period, none of the thinning that limits steroids on thin skin.
Weeks 1 to 4
Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.
Weeks 4 to 8
Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.
Weeks 8 to 12
Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.
After stopping
After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.
Side effects
Sorted by what to do about them.
Eucrisa
Vtama
Common
Common
- Burning or stinging where applied
Common
- Folliculitis (small red bumps at hair follicles)
- Itch, headache
Tell your doctor
Tell your doctor
- Stinging that doesn't settle
Tell your doctor
- Acne-like spots that persist
Stop and get care
Stop and get care
- Hives, swelling or trouble breathing
Stop and get care
- Spreading painful infection
Safety and who should avoid it
Pregnancy
Use care
Little absorbed but data limited; ask your clinician.
Ask first
Discuss with your clinician.
Breastfeeding
Use care
Keep it off the nipple.
Ask first
Discuss with your clinician.
Children
3 months and older
Approved from 3 months.
2 and older
Approved from 2 for eczema.
Monitoring
None
Judge at 4 weeks.
None
Review at 12 weeks.
Key interactions
None known
—
None known
—
Other cautions
Use care
Stinging is more common on broken skin.
Use care
Folliculitis-prone skin.
Cost and getting it
Getting it and cost
Cost is the obstacle here, not safety. It has been brand-name with no stocked generic for most of its life, and the cash price for a large tube is high. Generic availability changes, so ask the pharmacy.
Prior authorization is common. Plans usually want a topical steroid first, sometimes a calcineurin inhibitor too, which is cheaper as a generic. A savings card exists for people with commercial insurance, with terms that change often.
Tube size matters more than with most creams, because it goes on twice a day over an area. A small tube covering a child's whole body lasts days. Ask for the size that matches the area treated.
Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.
Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.
Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.
When you stop
Comes back?
Eczema can return; it can be restarted any time.
Some people stay clear for months after stopping.
Taper needed?
No.
No.
After the last dose
No rebound and no skin thinning.
Restart if plaques return.
Common questions
Eucrisa:Why does it sting?
Probably the drug itself acting on inflamed skin, not the base. It is the commonest complaint, worst in the first days, and fades within a week.
Eucrisa:Can I use it on my eyelids?
Thin skin is where it makes the most sense and it is used there, but not in the eye itself. Keep it off the lid margin.
Eucrisa:Is it as good as a steroid cream?
No, it is milder. Its advantage is delicate skin and long stretches without the thinning that limits steroids.
Eucrisa:How long can I use it for?
There is no set limit. On during flares, off in between, for as long as it helps.
Eucrisa:Can children use it?
It is licensed from three months of age.
Eucrisa:Does it work for anything other than eczema?
Licensed for atopic dermatitis. Doctors sometimes use it off-label for other inflammatory rashes, where the evidence is thinner.
Vtama:Is it a steroid?
No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.
Vtama:Can I put it on my face?
Yes — approved for the face and skin folds, one of its main advantages over a steroid.
Vtama:What are the little bumps I am getting?
Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.
Vtama:How long before I know if it works?
Give it twelve weeks. Some change usually shows by four.
Vtama:Can I stop once I am clear?
That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.
Vtama:Does it work for eczema too?
Yes, it is also approved for atopic dermatitis, in adults and in children from age two.
